TScan Therapeutics, Inc. (TCRX) Earnings Signals & AI Vibe Check
Cross-checked across multiple AI analysts and grounded in the latest SEC filing.
powered by: earningsVibe.ai
Question:
What is the latest filing signal for TScan Therapeutics, Inc.?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest
10-K, TScan Therapeutics, Inc.'s filing signal
turned positive.
earningsVibe SuperAnalyst™ Verdict:
TURNED POSITIVE
Signal Performance — Stock Price Since Filing
30-Day Change
-3.70%
from filing date
60-Day Change
Pending
from filing date
Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT
PERPLEXITY
Continuing Negative
GEMINI
Turned Positive
CLAUDE
Turned Negative
CHATGPT
Turned Positive
Unlock the Full Filing Analysis
See full earningsSig™ and risksSig™ analysis across 5,000+ companies
Get Started Free →No credit card required
Question:
What does TScan Therapeutics, Inc. actually do?
Answer:
TScan Therapeutics is a clinical-stage biotechnology company focused on developing T cell receptor (TCR)-engineered T cell (TCR-T) therapies for cancer and autoimmune disorders. Its lead product candidate, TSC-101, is in Phase 1 development for acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) patients undergoing allogeneic hematopoietic cell transplantation (HCT), aiming to eliminate residual disease and prevent relapse. The company is also developing TCR-T therapies for solid tumors, utilizing a multiplex approach to target multiple antigens simultaneously. TScan Therapeutics has an internal GMP manufacturing facility and is also working with a CDMO to scale production. The company has a collaboration with Amgen to identify targets for Crohn's disease.
Question:
What are TScan Therapeutics, Inc.'s revenue drivers?
Answer:
Revenue is primarily derived from collaboration and licensing agreements, with no current revenue from product sales. The company expects future revenue from these agreements and potential product sales upon regulatory approval.
Cut through noisy SEC filings to find the signal faster
Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.
Get Started Free →No credit card required